Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $10.82 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.